Quick Takeaways
- ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A for SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (SUPN).
- Disclosed ownership: 5.1%.
- Date of event: 30 Sep 2025.
ARMISTICE CAPITAL, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (SUPN)
- Filing Manager
- ARMISTICE CAPITAL, LLC
- Reporting Manager
- Armistice Capital, LLC
- Symbol
- SUPN
- Shares outstanding
- 56,047,431 shares
- Disclosed Ownership
- 2,836,000 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 18:27:08 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 15 May 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"ARMISTICE CAPITAL, LLC disclosed 5.1% ownership in SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (SUPN) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 14 Nov 2025, 18:27.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 5.1% | 2,836,000 | 0 | 2,836,000 | /s/ Steven Boyd | Steven Boyd - Managing Member | |
| Steven Boyd | 5.1% | 2,836,000 | 0 | 2,836,000 | /s/ Steven Boyd | Steven Boyd |